Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
2022-RA-1137-ESGO Use of an allogeneic, cell-based vaccine DCP-001 in high grade Serous Ovarian cancerpatients after primary treatment; A phase I clinical trial
Author / Creator:Vledder, Annegé ; van Zeeburg, Hester ; Pas, Rob ten ; Eerkens, Anje ; Brummel, Koen ; Wang Yin, Kiave Ho ; Tabruyn, Sebastien ; Singh, Satwinder Kaur ; de Bruyn, Marco ; Rovers, Jeroen ; Nijman, Hans Wilhelm
Publisher:Kidlington: BMJ Publishing Group Ltd
Journal title:International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A304-A304
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
219 CD47 and phosphatidylserine contribute to the interaction between antigen presenting cells and the allogeneic cell-based relapse vaccine DCP-001
Author / Creator:Zuo, Haoxiao ; Singh, Satwinder Kaur ; Lierop, Marie-José Van ; Kaspers, Jorn ; Bos, Remco ; Kamermans, Alwin ; Vries, Helga E de ; Gruijl, Tanja de ; Kruisbeek, Ada ; Manting, Erik
Journal title:Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A232-A232
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade
Author / Creator:Zuo, Haoxiao ; van Lierop, Marie-José C. ; Kaspers, Jorn ; Bos, Remco ; Reurs, Anneke ; Sarkar, Saheli ; Konry, Tania ; Kamermans, Alwin ; Kooij, Gijs ; de Vries, Helga E. ; de Gruijl, Tanja D. ; Karlsson-Parra, Alex ; Manting, Erik H. ; Kruisbeek, Ada M. ; Singh, Satwinder Kaur
Publisher:Switzerland: MDPI AG
Journal title:Cells (Basel, Switzerland), 2021-11, Vol.10 (11), p.3233
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer
Author / Creator:Nagasawa, Maho ; Bos, Remco ; Zuo, Haoxiao ; Wang Yin, Kiave Yune Ho ; Lierop, Marie-José van ; Tabruyn, Sebastien ; Manting, Erik ; Bruyn, Marco de ; Nijman, Hans ; Singh, Satwinder KAur ; Singh, Satwinder Kaur
Publisher:London: BMJ Publishing Group LTD
Journal title:Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A102-A103
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
Newsletter articlesFull Text
Immunicum: BioStock: Immunicum publishes DCP-001 data
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
Newsletter articlesFull Text
Press Release: Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
Newsletter articlesFull Text
Press Release: Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
Newsletter articlesFull Text
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
Publisher:Amman: Disco Digital Media, Inc
Journal title:ICT Monitor Worldwide, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
Newsletter articlesFull Text
Press Release: Immunicum AB: Immunicum to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Myeloid Leukemia
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
Newsletter articlesFull Text
Press Release: Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
Newsletter articlesFull Text
Immunomedics Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001
Publisher:Melbourne: News Bites Pty Ltd
Journal title:News Bites - Healthcare & Equipment, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
Newsletter articlesFull Text
Immunomedics Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
Publisher:Melbourne: News Bites Pty Ltd
Journal title:News Bites - Healthcare & Equipment, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
Newsletter articlesFull Text
Press Release: Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
Newsletter articlesFull Text
Immunomedics Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting
Publisher:Melbourne: News Bites Pty Ltd
Journal title:News Bites - Healthcare & Equipment, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newsletter articlesFull Text
Press Release: Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
Newsletter articlesFull Text
Press Release: Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
Newsletter articlesFull Text
Press Release: Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
Newsletter articlesFull Text
Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
Newsletter articlesFull Text
Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2021
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 37 results

Export record to excel

Export this record

Export record to excel

2022-RA-1137-ESGO Use of an allogeneic, cell-based vaccine DCP-001 in high grade Serous Ovarian cancerpatients after primary treatment; A phase I clinical trial

Export this record

Export record to excel

219 CD47 and phosphatidylserine contribute to the interaction between antigen presenting cells and the allogeneic cell-based relapse vaccine DCP-001

Export this record

Export record to excel

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade

Export this record

Export record to excel

171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer

Export this record

Export record to excel

Immunicum: BioStock: Immunicum publishes DCP-001 data

Export this record

Export record to excel

Press Release: Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells

Export this record

Export record to excel

Press Release: Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001

Export this record

Export record to excel

Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress

Export this record

Export record to excel

Press Release: Immunicum AB: Immunicum to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Myeloid Leukemia

Export this record

Export record to excel

Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting

Export this record

Export record to excel

Press Release: Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001

Export this record

Export record to excel

Immunomedics Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001

Export this record

Export record to excel

Immunomedics Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress

Export this record

Export record to excel

Press Release: Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress

Export this record

Export record to excel

Immunomedics Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting

Export this record

Export record to excel

Press Release: Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting

Export this record

Export record to excel

Press Release: Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting

Export this record

Export record to excel

Press Release: Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting

Export this record

Export record to excel

Press Release: Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021

Export this record

Export record to excel

Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

Refine your search